Lewis Wardale

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 6

Top Topics

Radical Prostatectomy

Prostate Cancer

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Lewis Wardale, Ryan Cardenas, Vincent J Gnanapragasam, Colin S Cooper, Jeremy Clark, Daniel S Brewer
Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis. Current oncology (Toronto, Ont.) 30 (1) (2022)
Lewis Wardale, Ryan Cardenas, Vincent J Gnanapragasam, Colin S Cooper, Jeremy Clark, Daniel S Brewer
Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis. Current oncology (Toronto, Ont.) 30 (1) (2022)
Lewis Wardale, Ryan Cardenas, Vincent J Gnanapragasam, Colin S Cooper, Jeremy Clark, Daniel S Brewer
Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis. Current oncology (Toronto, Ont.) 30 (1) (2022)
Lewis Wardale, Ryan Cardenas, Vincent J Gnanapragasam, Colin S Cooper, Jeremy Clark, Daniel S Brewer
Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis. Current oncology (Toronto, Ont.) 30 (1) (2022)
Lewis Wardale, Ryan Cardenas, Vincent J Gnanapragasam, Colin S Cooper, Jeremy Clark, Daniel S Brewer
Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis. Current oncology (Toronto, Ont.) 30 (1) (2022)
Lewis Wardale, Ryan Cardenas, Vincent J Gnanapragasam, Colin S Cooper, Jeremy Clark, Daniel S Brewer
Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis. Current oncology (Toronto, Ont.) 30 (1) (2022)